PerkinElmer to sell off units in deals worth $400m to focus on life sciences
PerkinElmer Inc. said yesterday it plans to sell businesses worth around $400 million to focus on faster-growing life sciences areas. (Full article: 335 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
